These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 12903996)

  • 1. Mixed-element capture agents: a simple strategy for the construction of synthetic, high-affinity protein capture ligands.
    Bachhawat-Sikder K; Kodadek T
    J Am Chem Soc; 2003 Aug; 125(32):9550-1. PubMed ID: 12903996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of novel mdm2 binding peptides by phage display.
    Böttger V; Böttger A; Howard SF; Picksley SM; Chène P; Garcia-Echeverria C; Hochkeppel HK; Lane DP
    Oncogene; 1996 Nov; 13(10):2141-7. PubMed ID: 8950981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transformation of low-affinity lead compounds into high-affinity protein capture agents.
    Reddy MM; Bachhawat-Sikder K; Kodadek T
    Chem Biol; 2004 Aug; 11(8):1127-37. PubMed ID: 15324814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expansion of protein interaction maps by phage peptide display using MDM2 as a prototypical conformationally flexible target protein.
    Burch L; Shimizu H; Smith A; Patterson C; Hupp TR
    J Mol Biol; 2004 Mar; 337(1):129-45. PubMed ID: 15001357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo.
    Midgley CA; Desterro JM; Saville MK; Howard S; Sparks A; Hay RT; Lane DP
    Oncogene; 2000 May; 19(19):2312-23. PubMed ID: 10822382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation of protein ligands from large peptoid libraries.
    Alluri PG; Reddy MM; Bachhawat-Sikder K; Olivos HJ; Kodadek T
    J Am Chem Soc; 2003 Nov; 125(46):13995-4004. PubMed ID: 14611236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient purification of recombinant proteins fused to maltose-binding protein by mixed-mode chromatography.
    Cabanne C; Pezzini J; Joucla G; Hocquellet A; Barbot C; Garbay B; Santarelli X
    J Chromatogr A; 2009 May; 1216(20):4451-6. PubMed ID: 19329121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble mimics of the cytoplasmic face of the human V1-vascular vasopressin receptor bind arrestin2 and calmodulin.
    Wu N; Macion-Dazard R; Nithianantham S; Xu Z; Hanson SM; Vishnivetskiy SA; Gurevich VV; Thibonnier M; Shoham M
    Mol Pharmacol; 2006 Jul; 70(1):249-58. PubMed ID: 16574744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of the p53-mdm2 and p53-MDMX interfaces.
    Böttger V; Böttger A; Garcia-Echeverria C; Ramos YF; van der Eb AJ; Jochemsen AG; Lane DP
    Oncogene; 1999 Jan; 18(1):189-99. PubMed ID: 9926934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of Mdm2 and MdmX fusion proteins alters p53 mediated transactivation, ubiquitination, and degradation.
    Ghosh M; Huang K; Berberich SJ
    Biochemistry; 2003 Mar; 42(8):2291-9. PubMed ID: 12600196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategy for purifying maltose binding protein fusion proteins by affinity precipitation.
    Raghava S; Aquil S; Bhattacharyya S; Varadarajan R; Gupta MN
    J Chromatogr A; 2008 Jun; 1194(1):90-5. PubMed ID: 18466911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of human peroxisome proliferator-activated receptors ligand binding domain-maltose binding protein fusion protein in Escherichia coli: a convenient and reliable method for preparing receptor for screening ligands.
    Li C; Tian M; Yuan Y; Zhou Q
    Assay Drug Dev Technol; 2008 Dec; 6(6):803-10. PubMed ID: 19090689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SAP couples Fyn to SLAM immune receptors.
    Chan B; Lanyi A; Song HK; Griesbach J; Simarro-Grande M; Poy F; Howie D; Sumegi J; Terhorst C; Eck MJ
    Nat Cell Biol; 2003 Feb; 5(2):155-60. PubMed ID: 12545174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification of a fragment of MDM2 for production of polyclonal antisera.
    Carstens BP; Perry ME
    Protein Expr Purif; 2001 Mar; 21(2):361-5. PubMed ID: 11237699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virtual interaction profiles of proteins.
    Wollacott AM; Desjarlais JR
    J Mol Biol; 2001 Oct; 313(2):317-42. PubMed ID: 11800560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and purification of maltose-binding protein fusions.
    Riggs P
    Curr Protoc Mol Biol; 2001 May; Chapter 16():Unit16.6. PubMed ID: 18265133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of an artificial tandem protein of the c-Myb DNA-binding domain and analysis of its DNA binding specificity.
    Oda M; Furukawa K; Sarai A; Nakamura H
    Biochem Biophys Res Commun; 1999 Aug; 262(1):94-7. PubMed ID: 10448074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of different tags on pulldown assays implemented by LMO2 fusion protein].
    Yuan W; Sun W; Yang S; Yan J; Zhai C; Du J; Wang Z; An D; Zhu T
    Sheng Wu Gong Cheng Xue Bao; 2008 May; 24(5):887-91. PubMed ID: 18724713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation of Hdmx mediates its Hdm2- and ATM-dependent degradation in response to DNA damage.
    Pereg Y; Shkedy D; de Graaf P; Meulmeester E; Edelson-Averbukh M; Salek M; Biton S; Teunisse AF; Lehmann WD; Jochemsen AG; Shiloh Y
    Proc Natl Acad Sci U S A; 2005 Apr; 102(14):5056-61. PubMed ID: 15788536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel unstructured scaffold based on 4EBP1 enables the functional display of a wide range of bioactive peptides.
    See HY; Lane DP
    J Mol Biol; 2010 Dec; 404(5):819-31. PubMed ID: 20932973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.